6 Endometrial Cancer Clinical Trials in Rochester, MN (2026)

Q: How do I join a clinical trial in Rochester?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Rochester research site will contact you.

Recruiting Endometrial Cancer Studies in Rochester

NCT06527157Recruiting

Investigations of Reproductive Cancers in Women

The goal of this study is to create a non-invasive diagnostic test to rule out gynecological cancer in females aged 45 and older with abnormal uterine or postmenopausal bleeding....

Rochester, MN4,500 participantsPinkDx, Inc.

View Study Details

NCT04291612Recruiting

Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease

This study is being done to find out how often endometrial cancer recurs after the standard treatment as well as how often the standard treatment results in a lymphedema....

Rochester, MN1,715 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT06365905Recruiting

Non-Invasive Identification of Endometrial Cancer/Endometrial Atypical Hyperplasia With an AI-Based Classifier Applied to Transvaginal Ultrasound in Patients With Post-Menopausal Bleeding

This study evaluates if AI can be used with transvaginal ultrasound images for early detection of endometrial cancer or premalignant lesions....

Rochester, MN300 participantsMayo Clinic

View Study Details

NCT07062016Recruiting

Molecular and ctDNA Characterization of High-Risk Endometrial Cancer

This study seeks to better understand the recurrence of high-risk endometrial cancer. It will collect information about cancer genetics to find out various hereditary or cancer specific genetic varian...

Rochester, MN100 participantsMayo Clinic

View Study Details

NCT07407959Recruiting

Screening and Staging of Benign vs Malignant Pelvic Abnormalities

This study evaluates whether newly developed non-FDA approved image processing techniques \[Adaptive Image Reconstruction (AIR Recon) Deep Learning (DL) and Sonic DL\] can provide improved quality and...

Rochester, MN60 participantsMayo Clinic

View Study Details

NCT07527143Recruiting

Acceptability of Testing DNA Markers in Vaginal Fluid for the Detection of Endometrial Cancer

This study evaluates how women feel about using DNA from a vaginal fluid collection for early detection of endometrial cancer....

Rochester, MN25 participantsMayo Clinic

View Study Details

About Endometrial Cancer Clinical Trials in Rochester

Endometrial cancer begins in the lining of the uterus and is the most common gynecologic cancer. It is often detected early due to abnormal bleeding symptoms. Treatment typically involves surgery, with radiation, chemotherapy, or hormone therapy for advanced cases.

There are currently 6 endometrial cancer clinical trials recruiting participants in Rochester, MN. These studies are seeking a combined 6,700 participants. Research is being sponsored by PinkDx, Inc., Memorial Sloan Kettering Cancer Center, Mayo Clinic. Clinical trial participation is free and participants receive study-related medical care at no cost.

Endometrial Cancer Clinical Trials in Rochester — FAQ

Are there endometrial cancer clinical trials in Rochester?

Yes, there are 6 endometrial cancer clinical trials currently recruiting in Rochester, MN. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Rochester?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Rochester research site will contact you about next steps.

Are clinical trials in Rochester free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Rochester studies also compensate for your time and travel.

What endometrial cancer treatments are being tested?

The 6 active trials in Rochester are testing new therapies including novel drugs, biologics, and treatment approaches for endometrial cancer.

Data updated July 13, 2026 from ClinicalTrials.gov